In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan.


Thrombosis is the formation of a blood clot (partial or complete blockage) within blood vessels, whether venous or arterial, limiting the natural flow of blood and resulting in clinical sequela. The ability of blood to flow freely in vessels relies on complex homeostasis that exists between blood cells (including platelets), plasma proteins, coagulation factors, inflammatory factors and cytokines, and the endothelial lining within the lumen of arteries and veins. When there is an imbalance with this physiologic process, there can be an increased risk of developing a thrombosis versus a coagulopathy (increased risk of bleeding). In certain clinical circumstances, patients can be at increased risk of thrombosis and bleeding simultaneously (e.g., disseminated intravascular coagulopathy-DIC, or in patients with underlying malignancy who develop a coagulopathy). As such, the diagnosis and management of thrombosis are complex. They can arise in any organ system, and their clinical presentation can vary depending on underlying comorbidities and presence (or absence) of provoking factors. Many factors can impact management decisions, including whether venous or arterial, acute or chronic, first or subsequent episode, family history, risk factor assessment, and hemodynamic stability. The use and duration of anticoagulation or antiplatelet therapy depend on a careful evaluation of these factors. Furthermore, a decision to pursue an exhaustive hypercoagulable workup to further evaluate for inherited or acquired conditions that predispose to thrombosis is controversial. It should only be completed in carefully selected patients or with subspecialty hematology evaluation prior.

Together, acute venous and arterial thrombosis accounts for the most common causes of death in developed countries. This mortality depends on location and acuity of thrombosis, with myocardial infarction and cerebrovascular accident (CVA) or stroke accounting for the highest proportion of thrombosis-associated death in the United States. An understanding of the basic pathophysiology of thrombosis and provoking risk factors can aid clinicians in the diagnosis, workup, and management of this condition. However, the topic is incredibly broad with many management-specific differences and decisions depending on etiology, risk factors, the location of thrombus (venous or arterial), and selection of anticoagulant or antiplatelet therapy. Many patients may require subspecialty evaluation with cardiologists, pulmonologists, neurologists, and/or hematologists. The state of the science on arterial and venous thrombosis is continually evolving, as is our understanding of provoking risk factors, hypercoagulability testing, and medical management.

There are also many unique presentations that add complexity to the diagnosis and treatment decisions, such as in acquired antiphospholipid syndrome or with heparin-induced thrombocytopenia & thrombosis (HITT). As such, many of these case- or disease-specific details and management aspects are beyond the scope of this review article. Readers are encouraged to consult additional references for further reading, including regularly-updated subspecialty society guidelines (e.g., American Society of Chest Physicians, American Heart Association, & American Society of Hematology). This review will focus primarily on the basic pathophysiology of venous and arterial thrombosis, including assessment of provoking risk factors and further workup that may be advisable following the initial presentation. This article will also briefly review the management of venous thrombosis and thromboembolism.

Publication types

  • Study Guide